Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Cost Effectiveness Of Sunitinib In Central America And Caribbean
Pfizer-sponsored trial evaluating the cost-effectiveness of sunitinib for metastatic renal cell carcinoma in Central America and the Caribbe…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: EPO906 Therapy in Patients With Advanced Kidney Cancer [Phase 2]
A Phase 2 trial of EPO906 Therapy in patients with advanced kidney cancer has completed, with an update from Novartis on the study status.
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer [Phase 2]
A Phase 2 trial of AG-013736 (axitinib) in patients with refractory metastatic renal cell carcinoma has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012
Pfizer conducted a retrospective observational update to report 5-year survival of subjects who participated in Axitinib trial A4061012; res…
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer [Phase 3]
Phase 3 trial update on axitinib as second-line therapy for metastatic renal cell cancer completed with results posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC) [Phase 2]
Phase 2 trial update of axitinib as second-line treatment for metastatic renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 study of AG-013736 (cediranib) in patients with metastatic renal cell carcinoma completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer [Phase 2]
This document reports the results of a Phase 2 clinical trial of a monoclonal antibody therapy in patients with metastatic renal cell carcin…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas [Phase 1]
Phase 1 trial evaluating carboxyamidotriazole in combination with paclitaxel for advanced solid tumors and refractory lymphomas has complete…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma [Phase 2]
This update reports a Phase II study of EC17, a folate-hapten conjugate, in patients with progressive metastatic renal cell carcinoma, which…
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 2]
A completed Phase 2 clinical trial evaluated the combination of sunitinib and erlotinib in patients with unresectable or metastatic kidney c…
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) [Phase 2]
A Phase 2 clinical trial update evaluating resection of pulmonary metastases in clear cell renal cell carcinoma with or without adjuvant sun…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab [Phase 2]
Phase 2 trial evaluating sorafenib in patients with metastatic kidney cancer that did not respond to sunitinib or bevacizumab. Results were …
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating low-dose decitabine plus interferon alfa-2b in advanced renal cell carcinoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma [Phase 2]
Phase II trial evaluating gemcitabine, capecitabine, and bevacizumab in metastatic renal cell carcinoma was terminated; results were posted …
-
CLINICAL_TRIALS trial_result · 2011-12-14Clinical Trial Update: Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer [Phase 3]
This clinical trial update reports the completion and posting of results for a Phase 3 study of sorafenib (BAY43-9006) in patients with unre…
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib
The document reports a completed clinical trial evaluating cognitive function in patients treated with sunitinib or sorafenib for metastatic…
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 2]
A Phase 2 study evaluating SU5416 in combination with interferon alfa-2b for unresectable or metastatic renal cell carcinoma has been comple…
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma
This University of Kansas–sponsored study on circulating tumor cells and circulating endothelial cells in renal cell carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Study of CP-461 in Patients With Advanced Renal Cell Cancer [Phase 2]
Phase 2 study of CP-461 in advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
Phase 2 trial evaluating the combination of Everolimus and Imatinib Mesylate for metastatic or unresectable kidney cancer; results were post…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma [Phase 1]
Phase 1b open-label dose-finding study assessing the safety of combining tivozanib with temsirolimus in metastatic renal cell carcinoma; the…
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma [Phase 1, Phase 2]
ClinicalTrials.gov update notes a completed Phase 1/2 study evaluating a combination of 5-fluorouracil, interferon-alpha, interleukin-2, and…
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors [Phase 4]
This Phase 4 clinical trial update discusses evaluating the optimal duration of therapy with oral angiogenesis inhibitors in patients with r…
-
CLINICAL_TRIALS trial_result · 2011-09-05Clinical Trial Update: Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) [Phase 2]
A Phase 2 trial comparing intermittent 4/2 dosing versus continuous dosing of sunitinib malate as first-line therapy for metastatic renal ce…